You have 8 free searches left this month | for more free features.

Check point inhibitor

Showing 51 - 75 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Atherosclerosis, Cardiovascular Diseases Trial in Cambridge (Written Informed Consent, Inclusion/Exclusion check, Full Clinical

Completed
  • Atherosclerosis
  • Cardiovascular Diseases
  • Written Informed Consent
  • +16 more
  • Cambridge, Cambridgeshire, United Kingdom
    Addenbrooke's Hospital
Jan 7, 2020

Locally Advanced/Metastatic Solid Tumors Trial in Newport Beach, San Diego, Canton (FL115)

Active, not recruiting
  • Locally Advanced/Metastatic Solid Tumors
  • Newport Beach, California
  • +2 more
Nov 10, 2023

Hernia, Inguinal, Chronic Pain, Seroma Trial in Nanchong (Lightweight mesh fixation)

Recruiting
  • Hernia, Inguinal
  • +5 more
  • Lightweight mesh fixation
  • Nanchong, Sichuan, China
    Yunhong Tian
Jun 30, 2023

NSCLC, Solid Tumor Trial in United States (Atezolizumab, Chemotherapy (Arm A Only), Tiragolumab)

Recruiting
  • Non-Small Cell Lung Cancer
  • Solid Tumor
  • Fort Myers, Florida
  • +6 more
Feb 16, 2022

Unresectable, Locally Advanced Or Metastatic Renal Cell

Completed
  • Locally Advanced or Metastatic Renal Cell Carcinoma
  • Cabozantinib monotherapy
  • All authorized TKI monotherapies in advanced RCC per FDA label in advanced RCC
  • The Woodlands, Texas
    McKesson Life Sciences
Nov 11, 2021

AEBT Website With Check-ins, AEBT Website Without Check-ins Trial (Acceptance-Enhanced Behavior Therapy)

Not yet recruiting
  • AEBT Website With Check-ins
  • AEBT Website Without Check-ins
  • Acceptance-Enhanced Behavior Therapy
  • (no location specified)
Nov 8, 2022

Angioedema Trial in Worldwide (Lanadelumab, Placebo)

Completed
  • Angioedema
  • Birmingham, Alabama
  • +44 more
Oct 24, 2022

Diabetes, Cellular Senescence, Sodium-Glucose Transporter 2 Inhibitors Trial in Seoul (SGLT2 inhibitor, Glimepiride)

Not yet recruiting
  • Diabetes Mellitus
  • +2 more
  • Seoul, Korea, Republic of
    Yonsei University College of Medicine
Aug 1, 2023

Advanced Malignant Solid Tumor Trial in Sacramento (CD24 Extracellular Domain-IgG1 Fc Domain Recombinant Fusion Protein CD24Fc,

Terminated
  • Advanced Malignant Solid Neoplasm
  • CD24 Extracellular Domain-IgG1 Fc Domain Recombinant Fusion Protein CD24Fc
  • Placebo Administration
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Mar 8, 2022

Advanced Cancer, Metastatic Cancer, Squamous Cell Carcinoma of Head and Neck Trial in United States (FS118)

Recruiting
  • Advanced Cancer
  • +2 more
  • Los Angeles, California
  • +6 more
Mar 3, 2022

Burnout Trial in Portland (Supervisor-employee frequent check-ins to identify and address work stressors, Usual practice

Not yet recruiting
  • Burnout
  • Supervisor-employee frequent check-ins to identify and address work stressors
  • Usual practice waitlist controls
  • Portland, Oregon
    OHSU
Jun 27, 2022

Liposarcoma, Dedifferentiated Trial (Brigimadlin)

Not yet recruiting
  • Liposarcoma, Dedifferentiated
  • (no location specified)
Sep 22, 2023

Atypical Hemolytic Uremic Syndrome (aHUS) Trial in Worldwide (Ravulizumab)

Active, not recruiting
  • Atypical Hemolytic Uremic Syndrome (aHUS)
  • Ravulizumab
  • Aurora, Colorado
  • +19 more
Nov 16, 2022

Effect on HIV Medications on EPC Cells

Completed
  • AIDS
  • Washington, District of Columbia
    The GW Medical Faculty Associates
Mar 21, 2022

Endometrial Endometrioid Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in

Completed
  • Endometrial Endometrioid Adenocarcinoma
  • +5 more
  • New Haven, Connecticut
  • +42 more
Jan 25, 2022

Club Foot Trial in Lahore (Low Dye Taping)

Recruiting
  • Club Foot
  • Low Dye Taping
  • Lahore, Punjab, Pakistan
    Children hospital
Mar 31, 2023

Teenagers and Non-histaminergic Angioedema With Normal C1

Not yet recruiting
  • Hereditary Angioedema (HAE)
  • Angioedema
  • No Intervention
  • (no location specified)
Jan 5, 2023

Advanced Malignant Solid Tumor, Stage III Cutaneous Melanoma AJCC v7, Stage III Prostate Cancer AJCC v7 Trial in New Brunswick

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +9 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jan 25, 2023

Urin-based Point-of-Care Testing for Direct Oral Anticoagulants

Recruiting
  • Stroke
  • Urin-based test by the DOASENSE Dipstick Device
  • Gießen, Hesse, Germany
    Department of Neurology, University Hospital Giessen
Sep 13, 2023

Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy Trial in Wuhan (drug, procedure, radiation)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Neoadjuvant Therapy
  • 3cycles (Toripalimab + cetuximab)
  • +2 more
  • Wuhan, Hebei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Aug 6, 2023

Following Menopause Treated WithNon-hormonal Therapy for Hot

Not yet recruiting
  • Hot Flashes
  • (no location specified)
Sep 18, 2023

Diffuse Glioma, Malignant Glioma Trial in Rochester (Biospecimen Collection, Computed Tomography, Eflornithine)

Not yet recruiting
  • Diffuse Glioma
  • Malignant Glioma
  • Biospecimen Collection
  • +6 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Feb 6, 2023

A Survey of Darvadstrocel in People With Crohn's Disease

Recruiting
  • Crohn's Disease
  • Darvadstrocel
  • Tokyo, Japan
    Takeda selected site
Dec 5, 2022

Hidradenitis Suppurativa Trial in Tampa, Baton Rouge (Placebo, Izokibep)

Recruiting
  • Hidradenitis Suppurativa
  • Tampa, Florida
  • +1 more
Jun 20, 2023

PTSD Trial in Boston (LDAEP, Placebo, sertraline)

Recruiting
  • Posttraumatic Stress Disorder
  • LDAEP
  • +2 more
  • Boston, Massachusetts
    VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
Mar 9, 2022